MoneyWorks4Me

Wockhardt gets nod to raise Rs 1,000 crore

06 Jan 2022 Evaluate

Wockhardt’s board has approved a proposal to raise up to Rs 1,000 crore through a rights issue. The objective of the issue is to meet the company's financing needs for repayment of subordinated debt due, financing research and development initiatives and general corporate purposes, among others, permitted by law.

Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.

Peers
Company Name CMP
Sun Pharma. Inds. 1784.25
Dr. Reddys Labs. 1197.35
Cipla 1335.60
Lupin 2012.00
Zydus Lifesciences 1141.00
View more..